Array Biopharma (ARRY) Tops Q3 EPS by 38c
Tweet
Share
E-mailGet Alerts ARRY Hot Sheet
Price: $12.23 +2.43%
EPS Growth %: -116.0%
Financial Fact:
Interest expense: -2.98M
Today's EPS Names:
NLY, CP, RUSHA, More
EPS Growth %: -116.0%
Financial Fact:
Interest expense: -2.98M
Today's EPS Names:
NLY, CP, RUSHA, More
Join SI Premium – FREE
Array Biopharma (NASDAQ: ARRY) reported Q3 EPS of $0.37, $0.38 better than the analyst estimate of ($0.01). Revenue for the quarter came in at $6.6 million versus the consensus estimate of $6 million.
For earnings history and earnings-related data on Array Biopharma (ARRY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meritage Homes Corporation (MTH) Tops Q1 EPS by 151c; offers guidance
- CVB Financial (CVBF) Tops Q1 EPS by 1c
- Northrim BanCorp (NRIM) Tops Q1 EPS by 54c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
